CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer
- PMID: 2199246
- DOI: 10.1016/0028-2243(90)90201-b
CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer
Similar articles
-
Immunodiagnosis of ovarian tumors.Immunol Ser. 1990;53:323-38. Immunol Ser. 1990. PMID: 2100566 Review. No abstract available.
-
[CA 125--a new characteristic in the diagnosis of ovarian carcinoma].Cesk Gynekol. 1987 Jun;52(5):381-5. Cesk Gynekol. 1987. PMID: 3477330 Czech. No abstract available.
-
[New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].Ann Ostet Ginecol Med Perinat. 1991 Jan-Feb;112(1):36-40. Ann Ostet Ginecol Med Perinat. 1991. PMID: 1929097 Italian.
-
Screening for ovarian cancer by CA-125 measurement.Lancet. 1988 Mar 5;1(8584):540-1. doi: 10.1016/s0140-6736(88)91345-1. Lancet. 1988. PMID: 2893964 No abstract available.
-
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.Important Adv Oncol. 1987:39-53. Important Adv Oncol. 1987. PMID: 3331386 Review. No abstract available.
Cited by
-
Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays.Cancer Immunol Immunother. 1995 Jan;40(1):24-30. doi: 10.1007/BF01517232. Cancer Immunol Immunother. 1995. PMID: 7828165 Free PMC article.
-
Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue.J Clin Pathol. 1995 Jul;48(7):631-6. doi: 10.1136/jcp.48.7.631. J Clin Pathol. 1995. PMID: 7560169 Free PMC article.
-
Prospects of chimeric antigen receptor T cell therapy in ovarian cancer.Med Oncol. 2018 Apr 12;35(5):70. doi: 10.1007/s12032-018-1131-6. Med Oncol. 2018. PMID: 29651744 Review.
-
Ovarian cancer immunotherapy: opportunities, progresses and challenges.J Hematol Oncol. 2010 Feb 10;3:7. doi: 10.1186/1756-8722-3-7. J Hematol Oncol. 2010. PMID: 20146807 Free PMC article. Review.
-
Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Acta Biochim Biophys Sin (Shanghai). 2016 Apr;48(4):301-17. doi: 10.1093/abbs/gmv128. Epub 2016 Jan 12. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 26764240 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials